Ann: Quarterly Report and Appendix 4C, page-20

Ok. So help me with this then.....

Seems I need a "little lesson".

Here is the clinical trial outline linked to from the NTI Clinical Trial Update 8th January:
https://clinicaltrials.gov/ct2/show/study/NCT02773303?term=Mente&rank=2

It says the trial's aims are:

This project aims:

• to further explore the effectiveness of a novel sonified Neurofeedback management therapy for children diagnosed with Autism Spectrum Disorder (ASD)
• to determine if balance control is different before and after therapy

And then the report presented at Cambridge Uni and summarised by NTI:

http://www.aspecthuntley.com.au/doc...Jyb3JwYWdlcy9wZGZkZWxheWVkLmpzcA==&popup=true

Says there were positive changes in neurological function.

BUT ... what neurological function?

The study was about balance control - not about Austism. (Not surprising because Dr Carrick is ..."known for establishing the chiropractic neurology subspecialty" and chiropractors would tend to be interested in balance.)

So I'm a bit puzzled. It seems the clinical study looks to have demonstrated improved balance control but nothing about Autism (or APD).

Help me out here please.